What's new

PSUSA/00010774/202403

PSUSA/00010774/202403

Feb 9, 2025 - 22:26
 0
PSUSA/00010774/202403
PSUSA/00010774/202403
Read More

Tags:

Previous Article

Questions and answers on implementation of the medical devices and in vitro diag...

Next Article

Human medicines European public assessment report (EPAR): Vumerity, diroximel fu...

Related Posts

Human medicines European public assessment report (EPAR): Tacforius, tacrolimus, Date of authorisation: 08/12/2017, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 25, 2025  0

EMEA-002198-PIP01-21-M01

EMEA-002198-PIP01-21-M01

Feb 14, 2025  0

Budesonide, gastro-resistant hard capsules, 3 mg, gastro- resistant granules, 9 mg product-specific bioequivalence guidance

Budesonide, gastro-resistant hard capsules, 3 mg, gastr...

Feb 12, 2025  0